These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. Chen M, Dong Y, Simard JM. J Neurosci; 2003 Sep 17; 23(24):8568-77. PubMed ID: 13679426 [Abstract] [Full Text] [Related]
26. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S. Eur J Pharmacol; 2001 Nov 09; 431(1):119-25. PubMed ID: 11716850 [Abstract] [Full Text] [Related]
29. Pilot study of intravenous glyburide in patients with a large ischemic stroke. Sheth KN, Kimberly WT, Elm JJ, Kent TA, Mandava P, Yoo AJ, Thomalla G, Campbell B, Donnan GA, Davis SM, Albers GW, Jacobson S, Simard JM, Stern BJ. Stroke; 2014 Jan 09; 45(1):281-3. PubMed ID: 24193798 [Abstract] [Full Text] [Related]
31. Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules. Nagamatsu S, Ohara-Imaizumi M, Nakamichi Y, Kikuta T, Nishiwaki C. Diabetes; 2006 Oct 09; 55(10):2819-25. PubMed ID: 17003348 [Abstract] [Full Text] [Related]